Monte Rosa Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
NEA MANAGEMENT COMPANY, LLC | 02/14/2025 | 7.69 M | $53.38 M | 0.00% | 9.38% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 7.12 M | $49.39 M | 7.81% | 8.68% |
VERSANT VENTURE MANAGEMENT, LLC | 02/12/2025 | 5.65 M | $39.23 M | 100.00% | 6.89% |
FMR LLC | 02/13/2025 | 5.55 M | $38.51 M | 8.76% | 6.77% |
BAKER BROS. ADVISORS LP | 02/14/2025 | 4.92 M | $34.12 M | 0.00% | 5.99% |
AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 4.35 M | $30.15 M | -24.96% | 5.30% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.84 M | $26.65 M | 32.35% | 4.68% |
VANGUARD GROUP INC | 02/11/2025 | 3.16 M | $21.91 M | 24.55% | 3.85% |
BVF INC/IL | 02/14/2025 | 2.76 M | $19.19 M | 100.00% | 3.37% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.56 M | $10.85 M | -41.19% | 1.91% |
AISLING CAPITAL MANAGEMENT LP | 02/12/2025 | 1.47 M | $10.22 M | 0.00% | 1.80% |
ALPHABET INC. | 02/07/2025 | 1.46 M | $10.16 M | 0.00% | 1.79% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.04 M | $7.20 M | -0.77% | 1.26% |
MARSHALL WACE, LLP | 02/13/2025 | 499,492 | $3.47 M | 187.31% | 0.61% |
NORGES BANK | 02/12/2025 | 445,868 | $3.09 M | 100.00% | 0.54% |
VESTAL POINT CAPITAL, LP | 02/14/2025 | 425,000 | $2.95 M | -54.30% | 0.52% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 370,472 | $2.57 M | 6.92% | 0.45% |
PARKWOOD LLC | 02/14/2025 | 323,000 | $2.24 M | -24.29% | 0.39% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 311,575 | $2.16 M | -0.01% | 0.38% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 278,785 | $1.93 M | 1,965.07% | 0.34% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 245,700 | $1.71 M | 12.35% | 0.30% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 221,741 | $1.54 M | 2.18% | 0.27% |
TD ASSET MANAGEMENT INC | 02/11/2025 | 220,096 | $1.53 M | 13.63% | 0.27% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 193,500 | $1.34 M | 172.15% | 0.24% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 170,312 | $1.18 M | 2.17% | 0.21% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 159,874 | $1.11 M | -10.49% | 0.19% |
JUMP FINANCIAL, LLC | 02/13/2025 | 154,842 | $1.07 M | 100.00% | 0.19% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 144,811 | $1.00 M | 3.98% | 0.18% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 117,412 | $814,839 | -0.39% | 0.14% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 102,835 | $713,675 | 0.00% | 0.13% |
QUEST PARTNERS LLC | 02/07/2025 | 94,633 | $656,753 | 100.00% | 0.12% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 92,818 | $644,156 | 100.00% | 0.11% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 91,274 | $633,442 | -0.02% | 0.11% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 86,545 | $600,622 | 100.00% | 0.11% |
CASDIN CAPITAL, LLC | 02/14/2025 | 86,014 | $596,937 | 0.00% | 0.10% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 76,850 | $533,339 | 27.31% | 0.09% |
BARCLAYS PLC | 02/13/2025 | 70,741 | $491,000 | 29.78% | 0.09% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 70,162 | $486,925 | 215.90% | 0.09% |
D. E. SHAW & CO., INC. | 02/14/2025 | 70,114 | $486,591 | 283.33% | 0.09% |
RHUMBLINE ADVISERS | 01/30/2025 | 61,791 | $428,821 | 17.77% | 0.08% |
UBS GROUP AG | 02/14/2025 | 59,399 | $412,229 | 134.47% | 0.07% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 46,370 | $321,808 | 51.43% | 0.06% |
CITIGROUP INC | 02/12/2025 | 44,883 | $311,489 | 49.10% | 0.05% |
LONG CORRIDOR ASSET MANAGEMENT LTD | 02/12/2025 | 40,000 | $277,600 | 0.00% | 0.05% |
WALLEYE CAPITAL LLC | 02/13/2025 | 39,647 | $275,150 | 100.00% | 0.05% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 35,140 | $243,872 | 0.00% | 0.04% |
STATE OF WISCONSIN INVESTMENT BOARD | 02/14/2025 | 32,382 | $224,731 | -10.79% | 0.04% |
CORTON CAPITAL INC. | 02/14/2025 | 32,366 | $224,620 | 100.00% | 0.04% |
SQUAREPOINT OPS LLC | 02/14/2025 | 31,654 | $219,679 | 100.00% | 0.04% |
EXCHANGE TRADED CONCEPTS, LLC | 01/21/2025 | 29,798 | $206,798 | 0.00% | 0.04% |
Monte Rosa Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 111 institutional investors and hedge funds held shares of Monte Rosa Therapeutics, Inc.. The most heavily invested institutionals were:
NEA Management Company, LLC: 7.69 M
PRICE T ROWE ASSOCIATES INC /MD/: 7.12 M
Versant Venture Management, LLC: 5.65 M
FMR LLC: 5.55 M
BAKER BROS. ADVISORS LP: 4.92 M
Avoro Capital Advisors LLC: 4.35 M
74.36% of Monte Rosa Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 60.50 M shares in the last 24 months. This purchase volume represents approximately $416.84 M in transactions.